DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Announcing a 2024 Annual Report
January 1, 2024

Providing a summary of physician certification annual data submitted to the medical marijuana use registry. Continue reading


Announcement
December 14, 2023

MQA Online Services will be unavailable from Friday, December 15, at 6:00 PM to December 17, at 12:00 PM EST. Continue reading